Year archive

SYNTARA LIMITED — 2012 filings

All 71 regulatory filings released by SYNTARA LIMITED (SNT) in 2012, sourced directly from the official regulator.

71 Filings

2012 Period

2012 filings (71)

Filing	Released	Lang
Appendix 3B - Exercise of Employee Options 11 pages 95.1KB Share Issue/Capital Change	2012-11-12	English
Appendix 3B - Exercise of Employee Options 11 pages 95.1KB Share Issue/Capital Change	2012-11-07	English
Appendix 3B - Option Exercise 11 pages 95.1KB Capital/Financing Update	2012-10-29	English
Trading Halt 2 pages 45.0KB Regulatory Filings	2012-10-25	English
IMPORTANT MILESTONE BRONCHITOL APPROVED BY NICE IN UK 2 pages 88.6KB Regulatory Filings	2012-10-25	English
Results of Meeting 2 pages 82.4KB Declaration of Voting Results & Voting Rights Announcements	2012-10-17	English
Appendix 3B - Option Issue 12 pages 103.2KB Share Issue/Capital Change	2012-10-17	English
Change of Director's Interest Notice 2 pages 74.0KB Director's Dealing	2012-10-17	English
Change of Director's Interest Notice 2 pages 74.5KB Director's Dealing	2012-10-17	English
Chairman's Address to Shareholders 3 pages 89.4KB AGM Information	2012-10-16	English
CEO Presentation to AGM 28 pages 4.5MB AGM Information	2012-10-16	English
Presentation at North American Cystic Fibrosis Conference 2 pages 110.2KB Regulatory Filings	2012-10-09	English
Appendix 4C - quarterly 5 pages 112.6KB Interim / Quarterly Report	2012-10-09	English
September 2012 Quarterly Report to Sharehholders 8 pages 1.9MB Interim / Quarterly Report	2012-10-09	English
Response to ASX Price Query 4 pages 166.8KB Regulatory Filings	2012-10-07	English
Quarterly Report and Investor Conference Call 1 pag Regulatory Filings	2012-10-07	English
Pharmaxis Receives Maximum Extension to German Patent 2 pages 83.8KB Regulatory Filings	2012-09-26	English
Investor Presentation 31 pages 5.0MB Investor Presentation	2012-09-12	English
Notice of Annual General Meeting/Proxy Form 2012 12 pages 657.6KB AGM Information	2012-09-10	English
Annual Report to shareholders 2012 95 pages 1.2MB Annual Report	2012-09-10	English
Investor Presentation 33 pages 4.7MB Investor Presentation	2012-08-15	English
Preliminary Final Report 47 pages 253.0KB Annual Report	2012-08-09	English
Appendix 3B - Employee Shares 11 pages 102.3KB Share Issue/Capital Change	2012-08-09	English
Proposed Grant of Options to New Director 2 pages 80.1KB Share Issue/Capital Change	2012-08-09	English
Independent Audit Report - 30 June 2012 2 pages 141.5KB Audit Report / Information	2012-08-09	English
US FDA Accepts Bronchitol New Drug Application for Review 2 pages 83.7KB Regulatory Filings	2012-08-01	English
Pharmaxis Announces New Board Appointment 1 page 91 Board/Management Information	2012-07-24	English
Initial Director's Interest Notice 2 pages 69.4KB Director's Dealing	2012-07-24	English
Appendix 3B - Exercise of Employee Options 11 pages 94.5KB Share Issue/Capital Change	2012-07-23	English
Appendix 4C - quarterly 5 pages 112.8KB Interim / Quarterly Report	2012-07-16	English
Quarterly Report to Shareholders - June 2012 8 pages 270.5KB Interim / Quarterly Report	2012-07-16	English
Pharmaxis Quarterly Investor Conference Call 1 page Call Transcript	2012-07-15	English
Ceasing to be a substantial holder 3 pages 31.5KB Major Shareholding Notification	2012-07-09	English
Becoming a substantial holder 7 pages 236.4KB Major Shareholding Notification	2012-07-04	English
Ceasing to be a substantial holder 3 pages 50.2KB Major Shareholding Notification	2012-07-03	English
Appendix 3B - Exercise of Employee Options 11 pages 94.4KB Capital/Financing Update	2012-07-01	English
Appendix 3B - Grant of Employee Performance Rights 12 pages 99.5KB Capital/Financing Update	2012-07-01	English
Proposed Issue of Performance Rights to CEO 2 pages 98.5KB Capital/Financing Update	2012-07-01	English
Becoming a substantial holder from UBS 7 pages 241.4KB Major Shareholding Notification	2012-06-28	English
Appendix 3B 11 pages 116.7KB Share Issue/Capital Change	2012-06-27	English
Change of Director's Interest Notice 2 pages 79.1KB Director's Dealing	2012-06-27	English
PHARMAXIS WELCOMES BRONCHITOL PBS LISTING ANNOUNCEMENT 2 pages 85.4KB Regulatory Filings	2012-06-24	English
Ceasing to be a substantial holder 3 pages 40.8KB Major Shareholding Notification	2012-06-18	English
Becoming a substantial holder 7 pages 224.4KB Major Shareholding Notification	2012-06-14	English
Additional Data Bronchitol Reduces Risk of Exacerbations 2 pages 113.2KB Regulatory Filings	2012-06-07	English
Bronchitol Commercial Progress in Europe 2 pages 137.1KB Regulatory Filings	2012-05-31	English
Appendix 3B - Exercise of Employee Options 11 pages 100.5KB Share Issue/Capital Change	2012-05-31	English
Pharmaxis Submits US New Drug Application for Bronchitol 2 pages 85.5KB Regulatory Filings	2012-05-20	English
Appendix 3B - Exercise of employee options 11 pages 100.5KB Share Issue/Capital Change	2012-05-20	English
Amended - Ceasing to be a substantial holder 4 pages 65.6KB Major Shareholding Notification	2012-05-15	English
Ceasing to be a substantial holder 3 pages 63.0KB Major Shareholding Notification	2012-05-09	English
Appendix 3B Exercise of Employee Options 11 pages 100.6KB Capital/Financing Update	2012-05-01	English
Pharmaxis Appoints New Chairman 2 pages 80.2KB Board/Management Information	2012-04-30	English
Final Director`s Interest Notice 2 pages 13.4KB Director's Dealing	2012-04-30	English
Investor Presentation 32 pages 3.8MB Investor Presentation	2012-04-26	English
Pharmaxis Receives Approval to Market Bronchitol in the EU 2 pages 85.4KB Regulatory Filings	2012-04-19	English
Appendix 4C - quarterly 5 pages 112.9KB Interim / Quarterly Report	2012-04-17	English
Pharmaxis Quarterly Report to Shareholders March 2012 8 pages 214.3KB Interim / Quarterly Report	2012-04-17	English
Becoming a substantial holder 8 pages 195.3KB Major Shareholding Notification	2012-04-16	English
PXS Completes Phase II study with ASM8 in asthma patients 3 pages 112.4KB Regulatory Filings	2012-04-16	English
Pharmaxis Quarterly Investor Conference Call 1 page Call Transcript	2012-04-16	English
Ceasing to be a substantial holder 3 pages 29.3KB Major Shareholding Notification	2012-04-12	English
Becoming a substantial holder 8 pages 234.8KB Major Shareholding Notification	2012-04-10	English
Pharmaxis Announces Agreement for EU Supply of Bronchitol 2 pages 83.3KB Capital/Financing Update	2012-03-28	English
European Regulatiry Update on Bronchitol 2 pages 80.5KB Regulatory Filings	2012-03-15	English
Bronchitol to be Reimbursed in Australia 2 pages 90.0KB Regulatory Filings	2012-03-13	English
Change of Director`s Interest Notice 2 pages 73.9KB Director's Dealing	2012-02-26	English
Half Yearly Report and Accounts 18 pages 294.1KB Interim / Quarterly Report	2012-02-02	English
Quarterly Report to Shareholders 8 pages 419.7KB Interim / Quarterly Report	2012-01-23	English
Appendix 4C - quarterly 5 pages 117.8KB Interim / Quarterly Report	2012-01-23	English
Quarterly Investor Conference Call 1 page 25.6KB Regulatory Filings	2012-01-22	English

Filings by year

2026 36 filings
2025 88 filings
2024 101 filings
2023 72 filings
2022 95 filings
2021 96 filings
2020 65 filings
2019 48 filings
2018 69 filings
2017 53 filings
2016 43 filings
2015 58 filings
2014 33 filings
2013 70 filings
2012 71 filings
2011 90 filings
2010 77 filings
2009 74 filings
2008 67 filings
2007 85 filings
2006 82 filings
2005 79 filings
2004 55 filings
2003 11 filings